May 28, 2019
5:1
For every share held, investors received 5.
The split itself did not change the total investment value.
IRLAB Therapeutics AB Class A (OTC:IRLAF) operates in the Pharmaceuticals: major industry.
IRLAB Therapeutics AB Class A company overviewIRLAB Therapeutics AB Class A's most recent stock split was on May 28, 2019. It was a 5-for-1 forward split, so shareholders received 5 shares for every share they held.
IRLAB Therapeutics AB Class A has split its stock once. This history records one forward split, on May 28, 2019.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In IRLAB Therapeutics AB Class A's 5-for-1 split on May 28, 2019, every share became 5 shares.
IRLAB Therapeutics AB Class A has not announced a new split in our records. Its most recent split was on May 28, 2019, 7 years ago. Companies announce splits in advance, and any new OTC:IRLAF split will appear on this page.
Already premium?